Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada-Reference-Cited by-同舟云学术

Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada

Published:2021-09-26 Issue: Volume: Page:1-10
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Beauchemin C.¹²^ORCID,Guinan K.²^ORCID,Claveau D.³^ORCID,Dufresne S. Frédéric⁴⁵^ORCID,Rotstein C.⁶^ORCID

Affiliation:

1. Faculté de Pharmacie, Université de Montreal, Montreal, Canada

2. PeriPharm Inc, Montreal, Canada

3. Medical Affairs, AVIR Pharma Inc, Blainville, Canada

4. Division of Infectious Diseases and Clinical Microbiology, Department of Medicine, Maisonneuve-Rosemont Hospital, Montreal, Canada

5. Department of Microbiology, Immunology and Infectious Diseases, Faculty of Medicine, Université de Montréal, Montreal, Canada

6. Immunocompromised Host Infectious Diseases Service, Division of Infectious Diseases, Department of Medicine, University Health Network, University of Toronto, Toronto, Canada

Funder

AVIR Pharma Inc

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2021.1981862

Reference41 articles.

1. The Prospective Antifungal Therapy Alliance®Registry: A Two-Centre Canadian Experience

2. Centers for Disease Control and Prevention. Fungal diseases 2017 [cited 2018 Jun 1]. Available from: https://www.cdc.gov/fungal/infections/index.html

3. Mucormycosis in Organ and Stem Cell Transplant Recipients

4. How I treat mucormycosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic and budgetary impact evaluation of isavuconazole (Cresemba®) versus voriconazole (Vfend®) for the treatment of patients with possible invasive aspergillosis from the perspective of the Brazilian supplementary health system;PLOS ONE;2024-03-01

2. Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities: A Multi-Center Retrospective Study;Journal of Fungi;2023-01-27